What proportion of patients with heart failure are candidates for sacubitril/valsartan? Differences between guideline recommendations and regulatory labels

28 August 2018 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 7 - Chronic heart failure – Treatment Pharmacotherapy ESC Premium Access ESC Congress 2018

About the speaker

Photo

University of Glasgow, Glasgow (United Kingdom of Great Britain & Northern Ireland)

8 More presentations in this session

Presentation thumbnail
Doctor I. Hernandez Gonzalez (Valladolid, ES)
Presentation thumbnail
Doctor T. Ichiki (Rochester, US)
Presentation thumbnail
Doctor S. Aktaa (Leeds, GB)
Presentation thumbnail
Professor M. Senni (Bergamo, IT)
Presentation thumbnail
Doctor M. Li (Osaka, JP)

The Event

Event poster

ESC Congress 2018

28 August 2018 14:00 CET

ESC 365 is supported by

ESC 365 is supported by